AudioCure

activeseries-b
series-b
Stage
2018
Founded
3
Investors

About

AudioCure Pharma is a Berlin-based pharmaceutical company focused on developing treatments for hearing disorders such as sudden sensorineural hearing loss and tinnitus. The company is currently advancing its lead compound AC102 through clinical trials, which has shown promising results in restoring hearing in preclinical models.

Explore AudioCure's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.